Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 10/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.55 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.55 |
| ▸ | GGH | Q92820 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.41 |
| ▸ | KDM4A | O75164 | 2/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.41 |
| ▸ | TET3 | O43151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9696087 | 1.00 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL1248320 | 1.00 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| Hydrochloric Acid SCHEMBL5575602 | 0.98 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| Hydrochloric Acid SCHEMBL5575609 | 0.98 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL25254699 | 0.93 | FOLH1 (0.48) | FOLH1NAALAD2RIMKLAGGH | |
| SCHEMBL9697168 | 0.89 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGH | |
| SCHEMBL29324448 | 0.89 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGH | |
| SCHEMBL9696078 | 0.89 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGH | |
| SCHEMBL7257519 | 0.87 | FOLH1 (0.56) | FOLH1NAALAD2RIMKLAGGH | |
| SCHEMBL6237815 | 0.86 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGGHCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005916-A | Modified polyamino acid derivative with conformational regulating capability, preparation and application thereof | 四川大学 | 2024-05-10 | — | — | CN | claimed |
| CN-119677795-A | Amphiphilic poly (amino acid) linear block copolymers and nanoparticles thereof for drug delivery applications | 纳诺瑟拉生物科学股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| US-20240218011-A1 | GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF | FIREFLY BIO, INC. | 2024-07-04 | — | — | US | disclosed |
| US-12018093-B2 | Hemiasterlin derivatives and antibody-drug conjugates including same | Sumitomo Pharma Co., Ltd. (JP) | 2024-06-25 | — | — | US | disclosed |
| CN-118005916-A | Modified polyamino acid derivative with conformational regulating capability, preparation and application thereof | 四川大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-118005931-A | Polymer nano material with metal binding capacity and preparation and application thereof | 四川大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-115135694-B | Polymeric excipients for drug delivery applications | 廷德尔配方服务有限责任公司 | 2024-03-15 | — | — | CN | disclosed |
| US-20240067640-A1 | PHENYL MALEIMIDE LINKER AGENTS | FIREFLY BIO, INC. | 2024-02-29 | — | — | US | disclosed |
| US-20230121556-A1 | COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2023-04-20 | — | — | US | disclosed |
| US-11541049-B2 | Tetrahydroisoquinoline derivatives, preparation process and use thereof | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-01-03 | — | — | US | disclosed |
| US-20150291648-A1 | N-SUBSTITUTED SECOND GENERATION DERIVATIVES OF ANTIFUNGAL ANTIBIOTIC AMPHOTERICIN B AND METHODS OF THEIR PREPARATION AND APPLICATION | BLIRT S.A. (PL) | 2015-10-15 | — | — | US | disclosed |
| EP-2861610-A1 | N-SUBSTITUTED SECOND GENERATION DERIVATIVES OF ANTIFUNGAL ANTIBIOTIC AMPHOTERICIN B AND METHODS OF THEIR PREPARATION AND APPLICATION | Blirt S.A. (PL) | 2015-04-22 | — | — | EP | disclosed |
| WO-2013186384-A1 | N-SUBSTITUTED SECOND GENERATION DERIVATIVES OF ANTIFUNGAL ANTIBIOTIC AMPHOTERICIN B AND METHODS OF THEIR PREPARATION AND APPLICATION | BLIRT S.A. (PL) | 2013-12-19 | — | — | WO | disclosed |
| EP-0711177-B1 | IMPROVEMENTS RELATING TO THE PREPARATION OF PRODRUGS | CANCER RES CAMPAIGN TECH (GB) | 2007-05-09 | — | — | EP | disclosed |
| EP-0744962-B1 | METHOD OF STORAGE OF ULTRASONIC GAS SUSPENSIONS | BRACCO RESEARCH SA (CH) | 2001-09-12 | — | — | EP | disclosed |
| US-5961956-A | GAS MICROBUBBLES IMMOBILISED WITHIN A FROZEN AQUEOUS CARRIER LIQUID; THE IMMOBILISED GAS MICROBUBBLES ARE MICROBUBBLES BOUND BY AN EVANESCENT ENVELOPE OR A TANGIBLE MEMBRANE. | BRACCO RESEARCH S.A. (CH) | 1999-10-05 | — | — | US | disclosed |
| US-5830435-A | BOUNDING BY ENVELOP OR MEMBRANE | BRACCO RESEARCH S.A. (NL) | 1998-11-03 | — | — | US | disclosed |
| US-5827504-A | SUSPENSION OF GAS MICROBUBBLES BOUNDED BY EVANESCENT ENVELOPE OR MEMBRANE IMMOBILIZED WITHIN FROZEN CARRIER LIQUID; ECHO IMAGING CONTRAST AGENT | BRACCO RESEARCH S.A. (CH) | 1998-10-27 | — | — | US | disclosed |
| EP-0744962-A1 | METHOD OF STORAGE OF ULTRASONIC GAS SUSPENSIONS | BRACCO RESEARCH S.A. (CH) | 1996-12-04 | — | — | EP | disclosed |
| WO-1996018420-A1 | METHOD OF STORAGE OF ULTRASONIC GAS SUSPENSIONS | BRACCO RESEARCH S.A. (CH) | 1996-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240218011-A1 | GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF | NR3C1, NR3C2, MC2R | FOLH1 2539/4885NAALAD2 1559/4885RIMKLA 4053/4885 |
| US-20230121556-A1 | COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE | LTB4R, LTC4S, LTA4H | FOLH1 276/4885NAALAD2 203/4885RIMKLA 2960/4885 |
| US-20150291648-A1 | N-SUBSTITUTED SECOND GENERATION DERIVATIVES OF ANTIFUNGAL ANTIBIOTIC AMPHOTERICIN B AND METHODS OF THEIR PREPARATION AND APPLICATION | ERG28, LSS, NPC1 | FOLH1 3609/4885NAALAD2 205/4885RIMKLA 546/4885 |
| US-20240067640-A1 | PHENYL MALEIMIDE LINKER AGENTS | TPX2, H1-4, MAPT | FOLH1 1549/4885NAALAD2 4083/4885RIMKLA 3147/4885 |
| US-11541049-B2 | Tetrahydroisoquinoline derivatives, preparation process and use thereof | CYP3A4, CYP3A43, CYP11B2 | FOLH1 1828/4885NAALAD2 3108/4885RIMKLA 1649/4885 |
| US-12018093-B2 | Hemiasterlin derivatives and antibody-drug conjugates including same | FCGRT, QARS1, INHA | FOLH1 4072/4885NAALAD2 984/4885RIMKLA 1754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.